• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Introduction to 3-methyl-1,2-benzoxazol-6-amine hydrochloride (CAS No. 1955506-56-5)

3-methyl-1,2-benzoxazol-6-amine hydrochloride, identified by its CAS number 1955506-56-5, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the benzoxazole class, a heterocyclic aromatic structure that has garnered considerable attention due to its diverse biological activities and potential therapeutic applications. The benzoxazole core is a key scaffold in drug discovery, known for its role in modulating various biological pathways, particularly those involving inflammation, neurodegeneration, and cancer.

The hydrochloride salt form of 3-methyl-1,2-benzoxazol-6-amine enhances its solubility and bioavailability, making it a valuable intermediate in the synthesis of more complex pharmacophores. The structural features of this molecule, including the presence of a methyl group at the 3-position and an amine functionality at the 6-position, contribute to its unique chemical properties and reactivity. These characteristics have been leveraged in recent studies to explore its potential as a precursor in the development of novel therapeutic agents.

In recent years, there has been growing interest in benzoxazole derivatives due to their demonstrated efficacy in preclinical models. Specifically, compounds with similar structures have shown promise in inhibiting enzymes and receptors involved in chronic diseases. For instance, research has highlighted the anti-inflammatory properties of certain benzoxazole derivatives by targeting cyclooxygenase (COX) and lipoxygenase (LOX) pathways. The amine group in 3-methyl-1,2-benzoxazol-6-amine hydrochloride suggests potential interactions with biological targets such as kinases and transcription factors, which are critical in regulating cellular processes.

One of the most compelling aspects of this compound is its versatility in medicinal chemistry. The benzoxazole ring can be further modified to introduce additional functional groups, allowing for the design of molecules with tailored pharmacological profiles. For example, studies have explored the use of benzoxazole derivatives as kinase inhibitors, particularly in the context of cancer therapy. The ability to fine-tune the structure has led to the discovery of several lead compounds that are currently undergoing further investigation.

The synthesis of 3-methyl-1,2-benzoxazol-6-amine hydrochloride involves multi-step organic reactions that require precise control over reaction conditions. The process typically begins with the formation of the benzoxazole core through cyclization reactions, followed by functionalization at specific positions using appropriate electrophilic or nucleophilic substitution strategies. The introduction of the methyl group and the amine functionality is achieved through selective alkylation and amination reactions, respectively. The final step involves converting the free base into its hydrochloride salt to improve stability and handling properties.

Recent advancements in synthetic methodologies have enabled more efficient and scalable production of this compound. Techniques such as flow chemistry and microwave-assisted synthesis have been employed to accelerate reaction times and improve yields. These innovations are particularly valuable in industrial settings where cost-effectiveness and reproducibility are paramount.

The pharmacological evaluation of 3-methyl-1,2-benzoxazol-6-amine hydrochloride has revealed several interesting findings. In vitro studies have demonstrated its ability to inhibit certain enzymes associated with pain signaling pathways, suggesting potential applications in analgesic therapies. Additionally, preliminary animal models have shown promising results in reducing inflammation without significant side effects. These findings have prompted further investigation into its mechanism of action and potential clinical applications.

One area of particular interest is the role of benzoxazole derivatives in neurodegenerative diseases. Research indicates that these compounds can modulate neurotransmitter systems and protect against oxidative stress-induced damage. The amine group in 3-methyl-1,2-benzoxazol-6-amine hydrochloride may play a crucial role in these interactions by serving as a hydrogen bond acceptor or participating in coordination with metal ions known to be involved in neurodegenerative processes.

The development of new drugs is often hampered by issues related to drug resistance and off-target effects. However, compounds like 3-methyl-1,2-benzoxazol-6-amine hydrochloride offer a promising alternative by targeting multiple pathways simultaneously. This multitargeting approach can enhance therapeutic efficacy while minimizing adverse effects. Furthermore, the structural flexibility of benzoxazole derivatives allows for rapid optimization based on computational modeling and experimental data.

In conclusion,3-methyl-1,2-benzoxazol-6-amine hydrochloride (CAS No. 1955506-56-5) represents a significant advancement in pharmaceutical research due to its versatile structure and potential therapeutic applications. Its role as an intermediate in drug synthesis underscores its importance in developing novel treatments for various diseases. As research continues to uncover new biological functions and synthetic strategies for this compound class,3-methyl-1,2-benzoxazol-6-amines will undoubtedly remain at the forefront of medicinal chemistry innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)